Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 71335-2204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
This text appears to be a statistical analysis of a study involving a drug called Spironolactone, compared to a placebo. The analysis includes a log-rank p-value indicating a significant difference between the two groups. The data also includes monthly time intervals from 4 to 48 months.*
Figure 2 (Spironolactone 03)
Label (Lbl713352204)
This text appears to be the description of a medication called Spironolactone Tablets USP. Each tablet contains 100 mg of Spironolactone, a prescription-only drug. It is important to keep this medication out of the reach of children and store it at a temperature between 20°C to 25°C (68°F to 77°F). The tablets are packaged in a tight, light-resistant container. The tablets are debossed with the code "MP 303" and have an NDC number of 71335-2204-1. The medication is produced by Bryant Ranch Prepack, Inc. and manufactured by Frontida BioPharm, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
